Differences in lipoprotein subfraction composition and distribution between type I diabetic men and control subjects

Area of Science:

• Endocrinology
• Lipid Metabolism
• Diabetic Complications

Background:

• Type I diabetes (insulin-dependent diabetes) is associated with dyslipidemia.
• Normolipidemic diabetic patients may still exhibit altered lipoprotein profiles.
• Lipoprotein abnormalities contribute to increased cardiovascular risk in diabetes.

Purpose of the Study:

• To investigate the composition of very-low-density and low-density lipoprotein subfractions in type I diabetic patients.
• To compare lipoprotein subfractions before and after improved glycemic control.
• To assess the impact of metabolic control on lipoprotein patterns and atherogenic risk.

Main Methods:

• Analysis of very-low-density and low-density lipoprotein subfractions in 10 male type I diabetic patients.
• Comparison with age-, BMI-, and lipid-matched male control subjects.
• Assessment of lipoprotein composition (lipids, apolipoproteins) before and after glycemic control improvement.

Main Results:

• Diabetic patients initially showed cholesterol-ester poor and triglyceride-rich lipoprotein subfractions, with higher non-apolipoprotein B proportions.
• Improved glycemic control partially normalized these compositional anomalies and reduced plasma subfraction concentrations.
• Lipoprotein profiles in treated diabetic patients more closely resembled those of control subjects.

Conclusions:

• Optimal insulinization is essential for normolipidemic type I diabetic patients to prevent potentially atherogenic lipoprotein modifications.
• Metabolic control significantly impacts lipoprotein subfraction composition and distribution.
• Addressing lipoprotein patterns is crucial for mitigating cardiovascular risk in diabetes.